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Background: Sonodynamic therapy (SDT) is a new approach for cancer treatment. Repair by reoxygenation
induces cell damage in all treatment which uses photo- and sonosensitizers. In this study, the in vivo antitumor
effect of dual-frequency sonication is investigated at low-level intensity and hematoporphyrin (Hp). It is used for
the treatment of spontaneous breast adenocarcinoma of Balb/c mice with a variety of dose repetition and
fractionation regimes.
Methods: Eighty tumor-bearing mice were divided into eight groups, the control group (A); the sham group (B);
the injection of Hp alone group (C); 30-min dual-frequency sonication with Hp injection in one repetition at the
first day group (D); two repetitions at the first and sixth days group (E); three repetitions at the first, sixth, and
twelfth days group (F); four repetitions at the first, sixth, twelfth, and eighteenth days (30 min/repetition) group (G);
and the fractional treatment group treated by dual-frequency sonication and Hp injection at the first, third, sixth,
and ninth days (7.5 min/fraction) (H). For each group, the tumor growth delay was calculated during 30 days after
treatment. These tumors were studied histopathologically.
Results: The results show that the treatment with ultrasound dose repetition in two, three, and four times (E, F, and G
groups) were effective in delaying tumor growth compared with one-time sonication (D group) (p < 0.05). Also, the
ultrasound dose fractionation is more effective in decreasing the tumor growth rate compared with the ultrasound
dose repetition in four repeats and in one repeat from the 12th to the 30th day (p < 0.05). Histopathological studies
indicated that the mitotic activity of tumor cells was reduced following treatment with four fraction and four repetition
protocols.
Conclusion: The ultrasound dose fractionation and repetition technique with dual-frequency sonication can have a
useful therapeutic effect in sonodynamic therapy with the possibility of use in future clinical applications.
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adenocarcinomaIntroduction
Breast cancer is one of the most deadly diseases for
women [1]. Over the years, three procedures for cancer
therapy have mostly been surgery, radiation, and chemo-
therapy [2]. Sonodynamic therapy (SDT) is a relatively
new approach for cancer treatment. It is based on photo-
dynamic therapy, which involves using synergistic effect
for killing cancerous cells through a combination of a drug* Correspondence: mokhtarm@modares.ac.ir
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(http://creativecommons.org/publicdomain/ze(a sonosensitizer) and ultrasound [3, 4]. Experiments with
low- and high-frequency ultrasound waves combined with
various sonosensitizers have shown that tumor volume
decreases or sonodynamic therapy causes a decline in
tumor growth rate [5–7]. A microbubble oscillates during
its oscillatory breathing under acoustic pressure. When it
reaches the resonant size at ultrasonic frequency, its oscil-
lation amplitude increases to an extreme level followed by
its catastrophic collapse, at which the gas inside gets adia-
batic compression causing its temperature rise to thou-
sands of degree centigrade. This high temperature leads tois an Open Access article distributed under the terms of the Creative Commons
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H2O molecules start to decompose into °H and °OH,
which either recombine, to form HO and H2, or alter the
chemistry of drugs [9, 10]. This way the suspended tumor
cells are killed by ultrasound at a much higher rate in the
presence of porphyrins [11].
The growth of experimental murine tumors was signifi-
cantly inhibited at low intensity ultrasound waves with a
porphyrin dose [12, 13]. Sonoexcitation of the tumor-
localizing components of hematoporphyrin (HP) derivative
leads to the production of singlet oxygen (1O2), which is the
main agent for induction of necrosis and regression of ma-
lignancies [14, 15]. The oxygen effect is important in radi-
ation therapy because malignant tumors usually have a
significant population of hypoxic cells. Reoxygenation is a
phenomenon in which hypoxic (and thus radioresistant)
tumor cells become more exposed to oxygen (and thus
more radiosensitive) by coming into closer proximity to ca-
pillaries after death of other tumor cells from previous ir-
radiation. If reoxygenation is applied efficiently between
dose fractions, the presence of hypoxic cells does not have
a significant impact on the outcome of a multifraction regi-
men [16–18]. Both in vitro and in vivo sonodynamical ex-
periment results have shown that the dual-frequency
ultrasound induces more cavitations than the conventionalFig. 1 The schematic diagram of the experimental setupsingle-frequency ultrasound under the same exposure con-
ditions. According to our previous studies [19], 30-min
dual-frequency sonication is a more potent inhibitor of
tumor growth than single-frequency sonication with and
without Hp injection.
The goal of this study is to assess the therapeutic
effect of repeated and fractionated dual-frequency son-
ication (1 MHz and 150 kHz) at lower level acoustic in-
tensity with hematoporphyrin for the treatment of
spontaneous breast adenocarcinoma in Balb/c mice.
Materials and methods
Hematoporphyrin (Sigma-Aldrich Co., Oakville, Canada)
has a purity of 50 % and is dissolved in phosphate buffered
saline (PBS, pH = 7.4) and stored in the dark at 4 °C. It
was injected at a dose of 10 mg/kg intraperitoneum injec-
tion, 6 h before sonication [20].
The cubic Perspex water tank (25, 25, and 30 cm3) is
built in an orthogonal geometry. Two ultrasonic probes
are positioned in a way that the central beam axis of
each probe is perpendicular to the axis of other. In
order to avoid the impact of reflection, the tank walls in
front of the probes were covered by a sheet of sound ab-
sorbent material (Fig. 1). The first source is a 150 kHz
(SM3670, Shrewsbury Medical Ltd., Shropshire, UK),
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quency with a 30-mm diameter and a 5-cm2 effective ra-
diation area (ERA). The other source is a 1 MHz
(Sonoplus 462 Enrof Nonius Co., Netherlands), 2.0 W/
cm2 (2.38 × 105 Pa), and a center frequency of 980 kHz
with a PZT transducer (30 mm diameter and 5 cm2
ERA). Acoustic calibration for the power and intensity
of sources was carried out in a degassed water tank
using the radiation force balance (UPM-DT-10, Netech,
USA, ±1 mW) and the hydrophone method in cubic
chamber (Bruel and Kjaer model 8103, Denmark). All
reported intensity values consist of the spatial average
and temporal average (SATA). For both sources, we
were able to change the intensity, mode of sonication,
and the duty cycle at the adjusted sonication.
We used repeated and fractionated irradiation with sim-
ultaneous dual-frequency ultrasound (continuous mode)
for 30-min sonodynamic therapy. In order to keep the
temperature of the tumor below the hyperthermia level, the
temperature rise during the exposure was checked by
thermometer with a 0.1-mm diameter micro-thermocouple
(CHY, 502A, Hsin-Chu, Taiwan), which was inserted on the
tumor under the skin of the animal. Temperature changes
as a result of sonication for 30 min were below the thresh-
old for producing hyperthermia effects (T < 35 °C) in all of
the experiments.
Breast adenocarcinoma tumor was supplied by the
Pasteur Institute, Tehran, Iran. All animal experi-
ments and protocols were evaluated and approved by
the Animal and Ethics Review Committee of the
Tarbiat Modares University (Tehran, Iran). Each
























Fig. 2 The mean ± SD of the relative volume change of tumor for all groups.
group; 30-min dual-frequency sonication with Hp injection in (D) one repetiti
the first and sixth days group (US(150 kHz + 1 MHz) + Hp)0,6; (F) three repetitions
four repetitions at the first, sixth, twelfth, and eighteenth days group (US(150 kHtrocar-injection of an approximately 1–2 cm3 piece of
fresh tumor into the flank region of female Balb/c in-
bred mice (6–8 weeks) weighing 19–21 g. When the
average volume of tumors reached approximately 1 cm3
(V0), the tumors were treated. Before treatment, the
hair over the tumors was shaved. The tumor-bearing
mice were divided into eight groups (72 mice): (A) the
control group; (B) the sham group; (C) the injection of
HP alone group; (D) 30-min dual-frequency sonication
with Hp injection in one repetition at the first day group
(US(150 kHz + 1 MHz) + Hp)0; (E) two repetitions at the
first and sixth days group (US(150 kHz + 1 MHz) + Hp)0,6;
(F) three repetitions at the first, sixth, and twelfth days
group (US(150 kHz + 1 MHz) + Hp)0,6,12; (G) four repeti-
tions at the first, sixth, twelfth, and eighteenth days
group (US(150 kHz + 1 MHz) + Hp)0,6,12,18; and (H) the
fractional treatment group treated by 7.5-min dual-
frequency sonication and Hp injection at the first, third,
sixth, and ninth days group (USfraction(150 kHz + 1 MHz) +
Hp)0,3,6,9.
Before sonication, mice were anesthetized with an
intra-peritoneum (ip) injection of ketamine/xylazine. A
tumor-bearing mouse was held vertically in degassed
water at 37 °C at 1 cm from each probe [21], so ultra-
sound waves can propagate through the tumor and the
skin without any other acoustic interference.
The therapeutic response is evaluated by observing
tumor growth for each group after sonodynamic therapy
and comparing the result with those from control,
sham, and other groups. The length (a), width (b), and
height (c) diameters of tumors were measured with a






(A) The control group; (B) the sham group; (C) the injection of HP alone
on at the first day group (US(150 kHz + 1 MHz) + Hp)0; (E) two repetitions at
at the first, sixth, and twelfth days group (US(150 kHz + 1 MHz) + Hp)0,6,12; (G)
z + 1 MHz) + Hp)0,6,12,18
Fig. 3 The tumor growth inhibition ratio in the experimental groups. (C) The injection of HP alone group, 30-min dual-frequency sonication
with Hp injection in (G) one repetition at the first day group (US(150 kHz + 1 MHz) + Hp)0, (E) two repetitions at the first and sixth days group
(US(150 kHz + 1 MHz) + Hp)0,6, (F) three repetitions at the first, sixth, and twelfth days group (US(150 kHz + 1 MHz) + Hp)0,6,12, (G) four repetitions at
the first, sixth, twelfth, and eighteenth days group (US(150 kHz + 1 MHz) + Hp)0,6,12,18
Fig. 4 The mean ± SD of the relative volume change of tumor for the
five groups. (A) The control group; (B) the sham group; (C) the injection
of HP alone group, 30-min dual-frequency sonication with Hp injection
in (G) four repetitions at the first, sixth, twelfth, and eighteenth days
group (US(150 kHz + 1 MHz) + Hp)0,6,12,18; and (H) the fractional treatment
group treated by 7.5-min dual-frequency sonication and Hp injection at
the first, third, sixth, and ninth days (USfraction (150 kHz + 1 MHz) + Hp)0,3,6,9
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c π6 and relative volume and inhibition ratio were calcu-
lated as follows (Fig. 2):
Relative volume ¼ 100 V−V 0
V
ð1Þ










and VV 0sham group are normalized tumor vol-
ume in the treatment and sham groups, respectively.
To evaluate the delay in tumor growth, the survival
time was measured. Survival time was measured from
the end of volume calculation time (after 30 days) to
death time. For histopathology, tumors were removed
from anesthetized mice, fixed in 37 % formaldehyde, and
embedded in paraffin wax. Then, sections of tissue were
cut and stained with hematoxylin and eosin (H&E).
After 30 days, three mice in each group were randomly
selected for histopathological examination using the
Bloom–Richardson (BR) grading [22] for breast cancer.
Tumor grades were determined based on the tumor tu-
bule formation (score 1), number of mitoses/10-high-
power fields (score 2), and nuclear grade (score 3).
Scores of 3–5, 6–7, and 8–9 indicated well-differentiated
(BR low grade), moderately differentiated (BR intermedi-
ate grade), and poorly differentiated (BR high grade) tu-
mors, respectively.Statistical analyses were performed by verifying nor-
mality and homogeneity of variables, and one-way ana-
lysis of variance (ANOVA) was performed with a 95 %
confidence interval. We used survival analysis with the
log-rank test for investigating survival times.
Results
Figure 4 shows the relative volume change in percent ver-
sus days after treatment. The results show that the treat-
ment with ultrasound dose repetition of two, three, and
four times (E, F, and G) were effective in delaying tumor
Fig. 5 The tumor growth inhibition ratio in the experimental groups. (C) The injection of HP alone group; 30-min dual-frequency sonication with Hp
injection in (G) four repetitions at the first, sixth, twelfth, and eighteenth days group (US(150 kHz + 1 MHz) + Hp)0,6,12,18; and (H) the fractional treatment
group treated by 7.5-min dual-frequency sonication and Hp injection at the first, third, sixth, and ninth days (USfraction (150 kHz + 1 MHz) + Hp)0,3,6,9
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There were significant differences in the relative volume
changes of tumors in these groups compared with the
sham, control, and treated with 10 mg/kg intraperitoneum
injection of Hp (A, B, and C) (p < 0.05) groups. There wereFig. 6 Kaplan–Meier survival analysis of experimental groups. (A) The control g
dual-frequency sonication with Hp injection in (D) one repetition at the first d
days group (US(150 kHz + 1 MHz) + Hp)0,6; (F) three repetitions at the first, sixth, an
the first, sixth, twelfth, and eighteenth days group (US(150 kHz + 1 MHz) + Hp
dual-frequency sonication and Hp injection at the first, third, sixth, and ninsignificant reductions in growth delay in groups with ultra-
sound dose repetition from 15th to 30th day after the first
treatment (E, F, and G) (p < 0.05).
The results of inhibition ratio in treated groups with
repeated dual-frequency sonication with Hp injectionroup; (B) the sham group; (C) the injection of HP alone group, 30-min
ay group (US(150 kHz + 1 MHz) + Hp)0; (E) two repetitions at the first and sixth
d twelfth days group (US(150 kHz + 1 MHz) + Hp)0,6,12; (G) four repetitions at
)0,6,12,18; and (H) the fractional treatment group treated by 7.5-min
th days (USfraction (150 kHz + 1 MHz) + Hp)0,3,6,9
F4
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In the repeated treatment groups (D, E, F, and G), the
inhibition ratio was more than 40 % at day 21 relative to
the Hp injection group (C) and reached to 50 % on the
30th day for the four times repeated treatment group. In
the treated group with four repetitions (G), the inhib-
ition ratio reached 50 % at the 30th day.
These results demonstrate that repetition of sonody-
namic therapy with 30-min dual-frequency sonication
and Hp injection is an effective treatment for the controlFig. 7 Histopathological images of the tumors on day 30 after treatment from
dual-frequency sonication with Hp injection in b one repetition at the first da
sixth days group (US(150 kHz + 1 MHz) + Hp)0,6 × 100; d three repetitions at the fi
four repetitions at the first, sixth, twelfth, and eighteenth days group (US(150 kH
by 7.5-min dual-frequency sonication and Hp injection at the first, third, sixth,of adenocarcinoma tumor growth relative to other
treated groups (C and D).
The treated group with four repetitions (G) was com-
pared with the fractional treatment group (H group) that
was treated by 7.5-min dual-frequency sonication and
Hp injection at the first, third, sixth, and ninth days
(USfraction (150 kHz + 1 MHz) + Hp)0,3,6,9 (Fig. 4). The results
show that the treatments in the treated groups G and H
were effective in delaying tumor growth compared with
the control, sham, and Hp injection groups (p < 0.05).the following experimental groups: a the sham group × 200; 30-min
y group (US(150 kHz + 1 MHz) + Hp)0 × 100; c two repetitions at the first and
rst, sixth, and twelfth days group (US(150 kHz + 1 MHz) + Hp)0,6,12 × 400; e
z + 1 MHz) + Hp)0,6,12,18 × 300; and f the fractional treatment group treated
and ninth days (USfraction (150 kHz + 1 MHz) + Hp)0,3,6,9 × 400 magnification
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ume change of tumor in the ultrasound dose fraction-
ation in group H compared to the ultrasound dose
repetition in group G from 24 days after treatment (p <
0.05), and there was no significant difference between
two groups before this time (p > 0.05).
Figure 5 shows the inhibition ratio versus different
days after treatment in experimental groups of injection
of Hp alone (Hp), treated with dual-frequency sonication
and Hp for four repetitions (30 min/repetition), and four
fractions at the first, third, sixth, and ninth days after
treatment (7.5 min/fraction). The treated group with
fractional therapy (H) had more effective inhibition ratio
than the treated group with repetition therapy (G). In
other words, the ultrasound dose fractionation is more
effective in decreasing tumor growth than the ultra-
sound dose repetition in four repeats and in one repeat
from the 12th to the 30th day. Therefore, the ultrasound
dose fractionation regime in sonodynamic therapy could
be effective in controlling tumor growth.
Figure 6 shows the results of the Kaplan–Meier sur-
vival for all groups. The survival period in the group
treated with fractionation dual-frequency sonication with
Hp injection was significantly longer than other groups.
According to the survival curve, in the period of 50–70
days after the first treatment, 20 % of the mice survived
in group E; 75–90 days after the first treatment, 20 % of
the mice survived in group F; 50–70 days after the first
treatment, 30 % of the mice survived in group G; and
50–80 days after the first treatment, 20 % of the mice
survived in group H.
To verify sonodynamic therapy results, histopathological
studies were performed in the different experimental groups
(Fig. 7a–f), based on the Bloom–Richardson classification
(Table 1). The sham group (Fig. 7a) showed some nuclear
polymorphism. In the group that received Hp injection and
dual-frequency sonication (Fig. 7b), the mitotic index of the
tumor was reduced. Results for the treated groups with Hp
injection and dual-frequency sonication were not very dif-






Dual-frequency sonication + Hp 1 2
Dual-frequency sonication + Hp (two repetitions) 1 2
Dual-frequency sonication + Hp (three repetitions) 1 2
Dual-frequency sonication + Hp (four repetitions) 1 1
Dual-frequency sonication + Hp (four fractions) 1 1treatment (Fig. 7c, d). Finally, in the groups that received
four repetitions and four fraction Hp with dual-frequency
sonication (Fig. 7e, f), although mitotic cells were still
present, their nuclear polymorphism was the lowest among
all of the groups. All groups were scored based on this clas-
sification method including the total tumor grading. Data
shows that the treatment with fractionation and four repeti-
tions yields the least score compared with other experimen-
tal groups. However, results of pathology indicated that the
mitotic activity of tumor cells was reduced following treat-
ment with fractionation and four repetition protocols.Discussion
In recent years, sonodynamic therapy has been widely
developed for the treatment of tumors.
In this study, the non-thermal effect of ultrasound
based on its inertial cavitation was especially utilized.
With ultrasound excitation in the presence of molecular
oxygen, the sonosensitizer produces singlet oxygen,
which is harmful to the cell function. It is believed that
singlet oxygen is the principal cytotoxic species involved
in sonodynamic therapy. Previous research has shown
that sonodynamic therapy using simultaneous dual- or
multi-frequency ultrasound would reduce the growth of
tumors [20, 21, 23]. Barati et al. [21] explained that
using a low-frequency ultrasound at kHz range induced
more transient cavitations than a high-frequency ultra-
sound. Maximum collapsing of bubbles happens when
dual- or multi-frequency ultrasound is used. Barati et al.
[24] used sonodynamic therapy on breast adenocarcin-
oma tumor by using dual-frequency ultrasound and
photophyrin sensitizer. Their results showed that using
dual-frequency ultrasound is more effective than using
single frequency. Also, the relative volume changes of
tumors show that in groups with one-time treatment,
tumor growth increased at the sixth, twelfth, and eight-
eenth days after treatment [19]. In this study, these
times were selected for repeated sonodynamic therapy








2 7 Moderately differentiated
(BR intermediate grade)
2
3 6 Moderately differentiated
(BR intermediate grade)
2
3 6 Moderately differentiated
(BR intermediate grade)
2
3 6 Moderately differentiated
(BR intermediate grade)
2
2 4 Well differentiated (BR low grade) 1
2 4 Well differentiated (BR low grade) 1
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spaces between fractions are due to reoxygenation of
tumors [18]. The mechanisms responsible for this
phenomenon have not been clearly established. Sug-
gested mechanisms include reduced oxygen consump-
tion by irradiated cells, rapid cell loss leading to tumor
shrinkage, migration of cells from hypoxic to oxygenated
areas, and improvements in tumor blood flow [25]. In
this study, the antitumor effect of the dual-frequency
sonication (1 MHz and 150 kHz) at low-level intensity
with the sonosensitizer of Hp was investigated in the
mode of dose repetition and fractionation regimes.
These effects have not yet been reported in sonodynamic
therapy. Accordingly, sonodynamic therapy in four repeti-
tions at the first, sixth, twelfth, and eighteenth days
(US(150 kHz + 1 MHz) + Hp)0,6,12,18 (30 min/repetition) and
four fractions at the first, third, sixth, and ninth days
(USfraction (150 kHz + 1 MHz) + Hp)0,3,6,9, after treatment
(7.5 min/fraction) is more effective than the other expos-
ure regimes (groups C, D, E, and F). The histopathological
studies supported our results and showed that the total
score of malignancy in the G and H groups was reduced,
and cells were more differentiated than those in the other
groups.
Indeed, the reduction in tumor growth days after treat-
ment is due to the cell killing because of increase in the
level of cavitations which produce free radicals and toxic
agents. Our results clearly showed that the repetition
and fractionation regimes give tissue the opportunity to
repair and resume reoxygenation process for damaged
cells caused by sonodynamic therapy. Sonochemical re-
actions also depend on the presence of oxygen in tumor
tissue. However, sonodynamic therapy induces severe
hypoxia in tumor tissue after the first irradiation, and
this condition is adverse to the induction of a sono-
chemical reaction. When more days were applied be-
tween therapy days, oxygen was induced in cells under
hypoxic conditions. Therefore, reoxygenation in hypoxic
cells returned to original levels when the oxygen supply
was resumed.Conclusion
In sonodynamic therapy, the ultrasound dose fractionation
and repetition with dual-frequency sonication can have a
useful therapeutic effect and may have future clinical
applications.Competing interests
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